PL2639239T3 - Usuwanie preparatów białkowych z preparatów biofarmaceutycznych w trybie przepływowym - Google Patents

Usuwanie preparatów białkowych z preparatów biofarmaceutycznych w trybie przepływowym

Info

Publication number
PL2639239T3
PL2639239T3 PL13275053T PL13275053T PL2639239T3 PL 2639239 T3 PL2639239 T3 PL 2639239T3 PL 13275053 T PL13275053 T PL 13275053T PL 13275053 T PL13275053 T PL 13275053T PL 2639239 T3 PL2639239 T3 PL 2639239T3
Authority
PL
Poland
Prior art keywords
removal
mode
flow
protein aggregates
biopharmaceutical preparations
Prior art date
Application number
PL13275053T
Other languages
English (en)
Inventor
Mikhail Kozlov
William Cataldo
Ajish Potty
Kevin Galipeau
James Hamzik
Joaquin Umana
Lars Peeck
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of PL2639239T3 publication Critical patent/PL2639239T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/52—Amides or imides
    • C08F220/54—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide
    • C08F220/58—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide containing oxygen in addition to the carbonamido oxygen, e.g. N-methylolacrylamide, N-(meth)acryloylmorpholine
    • C08F220/585—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide containing oxygen in addition to the carbonamido oxygen, e.g. N-methylolacrylamide, N-(meth)acryloylmorpholine and containing other heteroatoms, e.g. 2-acrylamido-2-methylpropane sulfonic acid [AMPS]
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B01D15/362—Cation-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J39/00—Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
    • B01J39/08—Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
    • B01J39/16—Organic material
    • B01J39/18—Macromolecular compounds
    • B01J39/20—Macromolecular compounds obtained by reactions only involving unsaturated carbon-to-carbon bonds
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J39/00—Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
    • B01J39/26—Cation exchangers for chromatographic processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J41/00—Anion exchange; Use of material as anion exchangers; Treatment of material for improving the anion exchange properties
    • B01J41/20—Anion exchangers for chromatographic processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J47/00—Ion-exchange processes in general; Apparatus therefor
    • B01J47/02—Column or bed processes
    • B01J47/026—Column or bed processes using columns or beds of different ion exchange materials in series
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/165—Extraction; Separation; Purification by chromatography mixed-mode chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/52—Amides or imides
    • C08F220/54—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide
    • C08F220/56—Acrylamide; Methacrylamide
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F222/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides, or nitriles thereof
    • C08F222/36—Amides or imides
    • C08F222/38—Amides
    • C08F222/385—Monomers containing two or more (meth)acrylamide groups, e.g. N,N'-methylenebisacrylamide
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B01D15/363—Anion-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804—Affinity chromatography
    • B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G, L chromatography

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Polymers & Plastics (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Engineering & Computer Science (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Graft Or Block Polymers (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL13275053T 2012-03-12 2013-03-12 Usuwanie preparatów białkowych z preparatów biofarmaceutycznych w trybie przepływowym PL2639239T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261609533P 2012-03-12 2012-03-12
US201261666578P 2012-06-29 2012-06-29
EP13275053.0A EP2639239B1 (en) 2012-03-12 2013-03-12 Removal of Protein Aggregates from Biopharmaceutical Preparations in a Flow-Through Mode

Publications (1)

Publication Number Publication Date
PL2639239T3 true PL2639239T3 (pl) 2018-03-30

Family

ID=48044702

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13275053T PL2639239T3 (pl) 2012-03-12 2013-03-12 Usuwanie preparatów białkowych z preparatów biofarmaceutycznych w trybie przepływowym

Country Status (10)

Country Link
US (2) US20130245139A1 (pl)
EP (3) EP2639239B1 (pl)
JP (3) JP5768070B2 (pl)
KR (4) KR101520753B1 (pl)
CN (3) CN103382215B (pl)
ES (2) ES2644744T3 (pl)
PL (1) PL2639239T3 (pl)
SG (1) SG10201701224UA (pl)
SI (1) SI2639239T1 (pl)
WO (1) WO2013138098A1 (pl)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101871683B1 (ko) 2010-07-30 2018-06-27 이엠디 밀리포어 코포레이션 크로마토그래피 매질 및 방법
WO2012149197A2 (en) 2011-04-27 2012-11-01 Abbott Laboratories Methods for controlling the galactosylation profile of recombinantly-expressed proteins
WO2013028330A2 (en) * 2011-08-19 2013-02-28 Emd Millipore Corporation Methods of reducing level of one of more impurities in a sample during protein purification
WO2013158279A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Protein purification methods to reduce acidic species
US9181572B2 (en) 2012-04-20 2015-11-10 Abbvie, Inc. Methods to modulate lysine variant distribution
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
EP2682168A1 (en) * 2012-07-02 2014-01-08 Millipore Corporation Purification of biological molecules
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
AU2013330344B2 (en) 2012-09-17 2018-07-05 W. R. Grace & Co.-Conn. Chromatography media and devices
EP2830651A4 (en) 2013-03-12 2015-09-02 Abbvie Inc HUMAN ANTIBODIES THAT BIND TNF-ALPHA AND PREPARATION METHODS
US10023608B1 (en) 2013-03-13 2018-07-17 Amgen Inc. Protein purification methods to remove impurities
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
LT3395423T (lt) 2013-03-14 2023-12-11 Amgen Inc. Pratekančių giminingumo gryninimo ligandų pašalinimas
US9499614B2 (en) 2013-03-14 2016-11-22 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosaccharides
US9598667B2 (en) 2013-10-04 2017-03-21 Abbvie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
WO2015073884A2 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
ES2810232T3 (es) * 2013-12-12 2021-03-08 Emd Millipore Corp Método de separación de proteína monomérica de agregados de proteínas con una membrana porosa que comprende un copolímero de acrilamida de bencilo y acrilamida
ES2887110T3 (es) 2014-01-16 2021-12-21 Grace W R & Co Medios para cromatografía de afinidad y dispositivos para cromatografía
EP3100050B1 (en) * 2014-01-31 2019-08-28 Enginzyme AB Immobilized proteins and use thereof
JP6914189B2 (ja) 2014-05-02 2021-08-04 ダブリュー・アール・グレース・アンド・カンパニー−コーンＷ Ｒ Ｇｒａｃｅ ＆ Ｃｏ−Ｃｏｎｎ 官能化担体材料並びに官能化担体材料を作製及び使用する方法
US10308678B2 (en) 2014-07-25 2019-06-04 Asahi Kasei Medical Co., Ltd. Cation exchange chromatographic support and method for using same
ES2877563T3 (es) * 2014-09-02 2021-11-17 Emd Millipore Corp Medios de cromotografía que comprenden conjuntos porosos discretos de nanofibrillas
WO2016093251A1 (ja) * 2014-12-08 2016-06-16 旭化成メディカル株式会社 生理活性物質の精製方法
WO2016093926A1 (en) 2014-12-08 2016-06-16 Emd Millipore Corporation Mixed bed ion exchange adsorber
JP2016210705A (ja) * 2015-04-30 2016-12-15 昭和電工株式会社 タンパク質凝集体の除去方法
EP3302784B1 (en) 2015-06-05 2021-10-06 W.R. Grace & Co.-Conn. Adsorbent bioprocessing clarification agents and methods of making and using the same
AU2016355739A1 (en) * 2015-11-18 2018-07-05 Merck Patent Gmbh Improved protein separation in ion exchange chromatography
CN106807330A (zh) * 2015-11-27 2017-06-09 中国科学院大连化学物理研究所 一种规整结构吸附材料的制备及吸附材料和应用
JP6621176B2 (ja) * 2016-01-22 2019-12-18 旭化成メディカル株式会社 タンパク質の精製方法
JP7032046B2 (ja) * 2016-01-22 2022-03-08 旭化成メディカル株式会社 生理活性物質の連続的な定流速精製方法
JPWO2017126496A1 (ja) * 2016-01-22 2018-08-23 旭化成メディカル株式会社 タンパク質の精製方法
EP3275897A1 (en) * 2016-07-27 2018-01-31 Biotest AG Process for preparing immunoglobulin compositions
WO2018043645A1 (ja) * 2016-08-31 2018-03-08 協和発酵キリン株式会社 活性炭を用いた蛋白質の精製方法
JP7085533B2 (ja) 2016-09-09 2022-06-16 スリーエム イノベイティブ プロパティズ カンパニー 官能化コポリマー及びその使用
JP6740357B2 (ja) 2016-09-09 2020-08-12 旭化成メディカル株式会社 強カチオン交換クロマトグラフィー担体及びその使用方法
EP3510041B1 (en) * 2016-09-09 2023-05-31 3M Innovative Properties Company Processes for separating aggregated proteins from monomeric proteins in a biological solution
WO2018087278A1 (en) * 2016-11-10 2018-05-17 Sandoz Ag Process for desalting of a protein solution
EP3758839A1 (en) 2018-02-27 2021-01-06 Life Technologies Corporation Flocculant functionalized separation media
WO2019173731A1 (en) * 2018-03-08 2019-09-12 Bio-Rad Laboratories, Inc. Anionic exchange-hydrophobic mixed mode chromatography resin
EP3546475A1 (en) * 2018-03-27 2019-10-02 Sanofi Full flow-through process for purifying recombinant proteins
KR20200138346A (ko) 2018-04-03 2020-12-09 메르크 파텐트 게엠베하 Cex 크로마토그래피 매질 및 생물제약 공급물로부터의 표적 단백질의 저염 용출
US11045773B2 (en) 2018-08-31 2021-06-29 Pall Corporation Salt tolerant porous medium
DE102018009597A1 (de) * 2018-12-07 2020-06-10 Sartorius Stedim Biotech Gmbh Vorrichtung und Verfahren zur mehrfachen Änderung der Zusammensetzung eines Fluids
KR20210118815A (ko) * 2019-01-23 2021-10-01 다이이찌 산쿄 가부시키가이샤 활성탄 재료를 사용하는 공정을 포함하는 항체 정제 방법
US10981950B2 (en) 2019-01-31 2021-04-20 Joanna Pezzini Therapeutic protein flow kit for a continuous purification system
JP2022546901A (ja) 2019-09-05 2022-11-10 バイオ－ラッド・ラボラトリーズ・インコーポレーテッド アニオン交換－疎水性混合モードクロマトグラフィー樹脂
CA3162172A1 (en) 2019-11-22 2021-05-27 Morphosys Ag Method to increase antibody yield during ion exchange chromatography
JP2023521193A (ja) * 2020-04-13 2023-05-23 スリーエム イノベイティブ プロパティズ カンパニー フロースループロセス及び標的分子を精製するためのデバイス
US20230235232A1 (en) * 2020-05-15 2023-07-27 Gary L. Stevenson Multistage oil reclamation system
US12050448B2 (en) 2021-01-29 2024-07-30 Tata Consultancy Services Limited Method and system to control a continuous bioprocessing
CN113416235B (zh) * 2021-06-24 2023-04-25 苏州赛分科技股份有限公司 用于纯化分离病毒类抗原的液相色谱法
CN113522256B (zh) * 2021-07-19 2022-06-21 中国科学院兰州化学物理研究所 一种水凝胶@二氧化硅液相色谱填料的制备及应用
KR20240046733A (ko) 2021-08-23 2024-04-09 제넨테크, 인크. 항체 약물 접합체에 대한 관류식 양이온 교환 크로마토그래피 정제 공정
CN118434753A (zh) * 2021-10-27 2024-08-02 等离子技术有限责任公司 用于分离蛋白质的组合物和方法

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4618533A (en) 1984-11-30 1986-10-21 Millipore Corporation Porous membrane having hydrophilic surface and process
US4944879A (en) 1989-07-27 1990-07-31 Millipore Corporation Membrane having hydrophilic surface
US6451260B1 (en) * 1997-08-26 2002-09-17 Dyax Corp. Method for producing microporous elements, the microporous elements thus produced and uses thereof
PT1084136E (pt) 1998-06-01 2004-12-31 Genentech Inc Separacao de monomeros de anticorpos dos seus multimeros atraves da utilizacao de cromatografia de troca ionica
US6783937B1 (en) * 1999-02-25 2004-08-31 Pall Corporation Negatively charged membrane
US6783713B2 (en) * 1999-05-03 2004-08-31 The Procter & Gamble Co. Filters for removal of pathogens from liquids
AUPQ389599A0 (en) * 1999-11-05 1999-12-02 Ilion Technology Corporation Polyelectrolyte gel
JP4918952B2 (ja) * 2001-03-28 2012-04-18 Ｄｉｃ株式会社 吸水性材料
US7318972B2 (en) * 2001-09-07 2008-01-15 Itm Power Ltd. Hydrophilic polymers and their use in electrochemical cells
US7118675B2 (en) 2002-02-04 2006-10-10 Millipore Corporation Process for removing protein aggregates and virus from a protein solution
KR101113201B1 (ko) * 2003-02-19 2012-04-12 나트릭스 세퍼레이션즈, 인코포레이티드 지지된 다공성 젤을 함유하는 복합재
EP1614693A4 (en) * 2003-03-31 2006-07-19 Kirin Brewery PURIFICATION OF A HUMAN MONOCLONAL ANTIBODY AND A HUMAN POLYCLONAL ANTIBODY
US7427659B2 (en) 2003-10-24 2008-09-23 Amgen Inc. Process for purifying proteins in a hydrophobic interaction chromatography flow-through fraction
RU2409591C2 (ru) 2003-10-27 2011-01-20 Вайет Удаление агрегатов с высокой молекулярной массой путем хроматографии на гидроксиапатитах
SE0302911D0 (sv) * 2003-10-31 2003-10-31 Amersham Biosciences Ab Novel separation matrix
JP4831436B2 (ja) * 2004-10-21 2011-12-07 ジーイー・ヘルスケア・バイオサイエンス・アクチボラグ クロマトグラフィーリガンド
US20070012345A1 (en) * 2005-01-24 2007-01-18 Owens Tony L Lower limb-support ambulatory device
CN104610422A (zh) 2005-03-11 2015-05-13 惠氏公司 弱分配层析的方法
WO2007018589A2 (en) * 2005-07-28 2007-02-15 Bio-Rad Laboratories, Inc. Separation of proteins based on isoelectric point using solid-phase buffers
US7674836B2 (en) * 2006-07-28 2010-03-09 3M Innovative Properties Company Method of making macroporous cation exchange resins
PL2061803T5 (pl) * 2006-08-28 2023-03-27 Ares Trading S.A. Proces oczyszczania białek zawierających fc
DE102006061327A1 (de) * 2006-12-22 2008-06-26 Basf Construction Polymers Gmbh Pfropf-Copolymer, Verfahren zu dessen Herstellung und seine Verwendung
EP2099957A1 (en) * 2007-01-10 2009-09-16 GE Healthcare Bio-Sciences AB Multi-modal ion exchange chromotography resins
DE102007012786A1 (de) * 2007-03-16 2009-01-08 Construction Research & Technology Gmbh Herstellung von sulfogruppenhaltigen Copolymeren
US20080257814A1 (en) 2007-04-23 2008-10-23 Millipore Corporation Filtration Cartridge
CA2687930C (en) * 2007-05-25 2016-05-17 Merck Patent Gesellschaft Mit Beschraenkter Haftung Graft copolymers for cation exchange chromatography
MX2009012786A (es) * 2007-06-01 2009-12-10 Hoffmann La Roche Purificacion de inmunoglobulina.
JP4897087B2 (ja) 2007-10-03 2012-03-14 ミリポア・コーポレイション 積層プレート式ろ過カートリッジ
JP5132278B2 (ja) * 2007-11-28 2013-01-30 一般財団法人川村理化学研究所 有機無機複合ヒドロゲルの製造方法
WO2009105191A2 (en) 2008-02-19 2009-08-27 Bloom Energy Corporation Fuel cell system containing anode tail gas oxidizer and hybrid heat exchanger/reformer
EP2153877A1 (de) * 2008-07-30 2010-02-17 MERCK PATENT GmbH Mischpfropfpolymere für die Ionenaustauschchromatographie
AU2008221604B2 (en) * 2008-09-22 2010-04-22 Commonwealth Scientific And Industrial Research Organisation Temperature-responsive polymer particles in protein separation applications
ES2661237T3 (es) * 2009-02-27 2018-03-28 Emd Millipore Corporation Membrana con grupos sulfónicos para eliminar agregados de proteína
MY152754A (en) * 2009-05-20 2014-11-28 Basf Se Hydrophobically associating copolymers
US8536316B2 (en) * 2009-08-07 2013-09-17 Emd Millipore Corporation Methods for purifying a target protein from one or more impurities in a sample
US20110301333A1 (en) * 2010-06-08 2011-12-08 Millipore Corporation Removal of protein aggregates from biopharmaceutical preparations using calcium phosphate salts
GB201012603D0 (en) * 2010-07-27 2010-09-08 Ucb Pharma Sa Protein purification
KR20130028939A (ko) * 2010-07-29 2013-03-20 이엠디 밀리포어 코포레이션 크로마토그래피 매질 성능을 개선하기 위한 그라프팅 방법
KR101871683B1 (ko) * 2010-07-30 2018-06-27 이엠디 밀리포어 코포레이션 크로마토그래피 매질 및 방법

Also Published As

Publication number Publication date
US20130245139A1 (en) 2013-09-19
CN104817611A (zh) 2015-08-05
KR20150093642A (ko) 2015-08-18
JP2018048162A (ja) 2018-03-29
JP5768070B2 (ja) 2015-08-26
CN103382215B (zh) 2016-08-24
US20180215786A1 (en) 2018-08-02
EP2639239A3 (en) 2013-11-20
JP6580650B2 (ja) 2019-09-25
EP2639239A2 (en) 2013-09-18
EP3312190B1 (en) 2020-05-27
JP2015110786A (ja) 2015-06-18
KR101601812B1 (ko) 2016-03-10
CN110256628A (zh) 2019-09-20
JP2013189427A (ja) 2013-09-26
WO2013138098A1 (en) 2013-09-19
EP2639239B1 (en) 2017-09-06
SI2639239T1 (sl) 2017-12-29
KR101520753B1 (ko) 2015-05-15
SG10201701224UA (en) 2017-04-27
EP3730510A1 (en) 2020-10-28
ES2644744T3 (es) 2017-11-30
KR101966692B1 (ko) 2019-04-09
EP3312190A1 (en) 2018-04-25
ES2812648T3 (es) 2021-03-17
KR20130105340A (ko) 2013-09-25
KR20140141562A (ko) 2014-12-10
KR20150043271A (ko) 2015-04-22
JP6231027B2 (ja) 2017-11-15
CN104817611B (zh) 2019-06-18
CN103382215A (zh) 2013-11-06

Similar Documents

Publication Publication Date Title
SI2639239T1 (sl) Odstranitev proteinskih agregatov iz biofarmacevtskih pripravkov v pretočnem načinu
IL269565A (en) KALLIKREIN PLASMA BINDING PROTEINS
HRP20181357T1 (hr) Novi postupci pročišćavanja proteina
IL230918A0 (en) Modified proteins and peptides
IL230439B (en) Genes and proteins for the synthesis of alkanoyl-coenzyme - a
EP2690173A4 (en) PROTEIN FOR AFFINITY CHROMATOGRAPHY SEPARATION MATRIX
EP2683362A4 (en) DISPERSIONS OF NANOPARTICLES OF PROTEINS
HK1202444A1 (en) Il-1 binding proteins il-1
ZA201400562B (en) Axmi205 variant proteins and methods for their use
EP2883882A4 (en) PROCESS FOR PURIFYING PROTEINS
HK1198832A1 (en) Fn14 binding proteins and uses thereof fn14
PL2858490T3 (pl) Rekombinowane elementy dna do ekspresji rekombinowanych białek w owadach
EP2701735A4 (en) LIQUID VACCINE COMPOSITIONS
HK1203404A1 (en) Serum amyloid p-antibody fusion proteins p-
EP2829603A4 (en) PROTEIN REGISTRATION PROCEDURES
EP2771689A4 (en) PEPTIDES USP2A AND ANTIBODIES
GB201121236D0 (en) Proteins and peptides
HUP1100282A2 (en) Protein factor
GB201121233D0 (en) Modified proteins and peptides
GB201121226D0 (en) Modified proteins and peptides
GB201104681D0 (en) Roles for chitinase-like proteins in disease states
GB201217405D0 (en) Protein removal agent
GB201215901D0 (en) Protein modification